Transfusion Medicine and Hemostasis

Direct Antiglobulin Test

Direct antiglobulin test (DAT [e.g., Coombs’]) detects in vivo sensitization of RBCs with immunoglobulins and/or complement. DAT is useful in investigation of acute and delayed hemolytic transfusion reaction (AHTR and DHTR), hemolytic disease of the fetus and newborn (HDFN), autoimmune hemolytic…

Antibody Identification

Antibodies to RBC antigens except anti-A and anti-B are called unexpected antibodies. Unexpected RBC antibodies may be alloantibodies reacting against foreign antigens or autoantibodies reacting against self-antigens. Depending on the patient population, 1%–35% of patients have unexpected alloantibodies. Once an…

Pretransfusion Testing

Pretransfusion testing is performed to select compatible blood components for transfusion, thereby preventing harm to recipient and maximizing posttransfusion survival. AABB Standards require the following: 1. Positive patient identification and their corresponding blood specimen; 2. ABO group and D typing…

Bacterial Screening

Bacterial contamination of blood components may result in septic transfusion reactions ( Chapter 67 ), which can be fatal. Platelet products, particularly those on day 4 or 5 of storage, are most commonly associated with these reactions because they are…

Babesia Screening

Babesia microti is the leading red blood cell (RBC) transfusion-transmitted pathogen reported to the FDA. Babesiosis most commonly occurs after a tick bite but can be transfusion-transmitted and vertically transmitted. Owing to the increasing incidence of babesiosis and transfusion-transmitted babesiosis…

Zika Virus Screening

In 2016, the association between maternal Zika viral infection and microcephaly in babies was recognized. Zika virus is spread through mosquitoes, sexual transmission, and potentially through transfusion. Owing to its associated morbidity, FDA recommended screening the blood supply by nucleic…